NM_170682.4:c.1310G>A
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_170682.4(P2RX2):c.1310G>A(p.Arg437Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000645 in 1,613,126 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_170682.4 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal dominant nonsyndromic hearing loss 41Inheritance: AD Classification: STRONG, LIMITED Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
- nonsyndromic genetic hearing lossInheritance: AD Classification: MODERATE Submitted by: ClinGen
- autosomal dominant nonsyndromic hearing lossInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.0000526  AC: 8AN: 152154Hom.:  0  Cov.: 33 show subpopulations 
GnomAD2 exomes  AF:  0.0000560  AC: 14AN: 250126 AF XY:  0.0000665   show subpopulations 
GnomAD4 exome  AF:  0.0000657  AC: 96AN: 1460972Hom.:  0  Cov.: 34 AF XY:  0.0000674  AC XY: 49AN XY: 726838 show subpopulations 
Age Distribution
GnomAD4 genome  0.0000526  AC: 8AN: 152154Hom.:  0  Cov.: 33 AF XY:  0.0000673  AC XY: 5AN XY: 74320 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
not specified    Uncertain:1Benign:1 
The c.1388G>A (p.R463Q) alteration is located in exon 10 (coding exon 10) of the P2RX2 gene. This alteration results from a G to A substitution at nucleotide position 1388, causing the arginine (R) at amino acid position 463 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
p.Arg463Gln in exon 10 of P2RX2: This variant is not expected to have clinical s ignificance because the arginine (Arg) residue at position 463 is not conserved through species, with at least 4 mammals (gorilla, chinchilla, brush-tailed rat and horse) having a glutamin (Gln) at this position. It has been identified in 6 /65582 European chromosomes by the Exome Aggregation Consortium (ExAC, http://ex ac.broadinstitute.org; dbSNP rs115260724). -
P2RX2-related disorder    Uncertain:1 
The P2RX2 c.1388G>A variant is predicted to result in the amino acid substitution p.Arg463Gln. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0094% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at